[HTML][HTML] Neoadjuvant chemotherapy for colorectal liver metastases: a contemporary review of the literature
Colorectal carcinoma (CRC) is one of the leading causes of cancer-related deaths
worldwide, and up to 50% of patients with CRC develop colorectal liver metastases (CRLM) …
worldwide, and up to 50% of patients with CRC develop colorectal liver metastases (CRLM) …
Perioperative management of complex hepatectomy for colorectal liver metastases: the alliance between the surgeon and the anesthetist
E Giustiniano, F Nisi, L Rocchi, PC Zito, N Ruggieri… - Cancers, 2021 - mdpi.com
Simple Summary Major high-risk surgery (HRS) exposes patients to potential perioperative
adverse events. Hepatic resection of colorectal metastases can surely be included into the …
adverse events. Hepatic resection of colorectal metastases can surely be included into the …
Artificial intelligence-assisted reduction in patients' waiting time for outpatient process: a retrospective cohort study
X Li, D Tian, W Li, B Dong, H Wang, J Yuan, B Li… - BMC health services …, 2021 - Springer
Background Many studies suggest that patient satisfaction is significantly negatively
correlated with the waiting time. A well-designed healthcare system should not keep patients …
correlated with the waiting time. A well-designed healthcare system should not keep patients …
Fatty liver: the metabolic syndrome increases major hepatectomy mortality
AM Fagenson, HA Pitt, AS Moten, SS Karhadkar… - Surgery, 2021 - Elsevier
Background As the obesity epidemic worsens, the prevalence of fatty liver disease has
increased. However, minimal data exist on the impact of combined fatty liver and metabolic …
increased. However, minimal data exist on the impact of combined fatty liver and metabolic …
Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores——A retrospective, propensity …
FL Chen, YY Wang, W Liu, BC Xing - Frontiers in Oncology, 2022 - frontiersin.org
Background The use of neoadjuvant chemotherapy (NAC) in resectable colorectal liver
metastases (CRLM) patients is controversial. High-risk patients are more likely to benefit …
metastases (CRLM) patients is controversial. High-risk patients are more likely to benefit …
Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy
YS Yeh, HL Tsai, YC Chen, WC Su, PJ Chen… - Oncology …, 2023 - pmc.ncbi.nlm.nih.gov
The controversial outcomes in patients with metastatic colorectal cancer (mCRC) highlight
the need for developing effective systemic neoadjuvant treatment strategies to improve …
the need for developing effective systemic neoadjuvant treatment strategies to improve …
[HTML][HTML] Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
Y Zhang, L Ge, J Weng, WY Tuo, B Liu… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND In recent years, neoadjuvant chemotherapy (NAC) has been increasingly
used in patients with resectable colorectal liver metastases. However, the efficacy and safety …
used in patients with resectable colorectal liver metastases. However, the efficacy and safety …
Neoadjuvant chemotherapy does not increase risk for anastomotic leak for simultaneous resection of primary colon cancer with synchronous liver metastasis: A NSQIP …
MM Mankarious, AC Portolese… - Journal of surgical …, 2023 - Wiley Online Library
Abstract Background and Objectives In patients with colon cancer with synchronous liver
metastasis, treatment algorithms are complex and often require multidisciplinary evaluation …
metastasis, treatment algorithms are complex and often require multidisciplinary evaluation …
[HTML][HTML] When does a Pringle Maneuver cause harm?
AM Fagenson, EM Gleeson, F Nabi, KN Lau, HA Pitt - Hpb, 2021 - Elsevier
Abstract Background The Pringle Maneuver (PM) is considered to be safe and effective.
However, data regarding perioperative outcomes after a PM are conflicting. Therefore, the …
However, data regarding perioperative outcomes after a PM are conflicting. Therefore, the …
When is a ghost really gone? A systematic review and meta-analysis of the accuracy of imaging modalities to predict complete pathological response of colorectal …
Background Administration of chemotherapy to patients with colorectal liver metastases may
result in disappearing liver metastases (DLM). This poses a therapeutic dilemma due to the …
result in disappearing liver metastases (DLM). This poses a therapeutic dilemma due to the …